The CXCL Family Contributes to Immunosuppressive Microenvironment in Gliomas and Assists in Gliomas Chemotherapy - Wang, Zeyu; Liu, Yuze; Mo, Yuyao; Zhang, Hao; Dai, Ziyu; Zhang, Xun; Ye, Weijie; Cao, Hui; Liu, Zhixiong; Cheng, Quan (Frontiers in immunology, 2021)
Keywords: Antineoplastic Agents - therapeutic use; Brain Neoplasms - drug therapy; Brain Neoplasms - genetics; Brain Neoplasms - immunology; Brain Neoplasms - metabolism; Chemokines, CXC - genetics; Chemokines, CXC - metabolism; chemotherapy; Clinical Decision-Making; CXCL; Databases, Chemical; Databases, Genetic; Gene Expression Profiling; Glioma - drug therapy; Glioma - genetics; Glioma - immunology; Glioma - metabolism; gliomas; Humans; immune checkpoint genes; Immunology; immunosuppressive; Nomograms; Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors; Thiazoles - therapeutic use; Transcriptome; Tumor Microenvironment - immunology; CXCL; immunosuppressive; immune checkpoint genes; gliomas; chemotherapy